Leonard is an editor of BioTuesdays.com. Before joining the blog, Leonard amassed 36 years of experience as a financial journalist, editor and manager with The Wall Street Journal and Dow Jones News Service, and The Globe and Mail’s Report on Business, where he pioneered the development and launch of the newspaper’s Money & Markets section in the early 1990s. Most recently, he was Canada’s leading biotechnology and healthcare writer, as well as the author of a highly popular stock market blog on globeandmail.com.
I am a Professional in the Biotech industry and I am working for a Large Pharmaceutical Company. My duties there are mainly to assess the develop-ability of cell culture derived therapeutic proteins such as monoclonal antibodies, antibody-drug-conjugates, Fusion proteins etc.
My main focus is analysis of biophysical properties of those molecules and pick the molecules with the highest probability of success based on various parameters. Furthermore, I am leading efforts to address issues such as solubility and shelf life of proteins. I hold two Master degrees, one in Biotechnology, the other one in Biotech - Management.
Please feel free to contact me if you have any scientific questions, I will help out with my best knowledge.
PS: Please keep in mind that my field of expertise are Biologics but not small molecule drugs.
A 20 year career of executive leadership in IT with specialization in database development, IT strategies and financial analysis. I've led the formation and development of several technology companies and have experienced the success and challenges that serial entrepreneurship brings.
As a long conservative investor, I've learn hard-taught lessons on the differences between speculation, trading, and investing.
Always looking for proven guidance.